Vaccine formulations and uses thereof

Details for Australian Patent Application No. 2009313912 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Oberreither, Manfred; Tauer, Christa; Falkner, Falko-Guenter

Agent Peter Maxwell & Associates

Pub. Number AU-A-2009313912

PCT Pub. Number WO2010/056991

Priority 12/271,522 14.11.08 US

Filing date 13 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 39/285 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056991 Priority application(s): WO2010/056991

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313918-Method of qualifying light spots for optical measurements and measurement instrument employing method of qualifying light spots

2009313906-Treatment of proteinopathies using a farnesyl transferase inhibitor